Clinical Trial

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

Study Description

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

VAY736 dose testing; VAY736 efficacy and safety testing.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Biological - VAY736

VAY736

Placebo

Placebo control with conversion to active VAY736

Additional Information

Official Study Title

A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis

Clinical Trial ID

NCT03217422

ParticipAid ID

ZdPknb